Arden Trust’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q2 | – | Sell |
-10
| Closed | -$5K | – | 657 |
|
2020
Q1 | $5K | Buy |
+10
| New | +$5K | ﹤0.01% | 640 |
|
2019
Q1 | – | Sell |
-1,180
| Closed | -$441K | – | 380 |
|
2018
Q4 | $441K | Sell |
1,180
-131
| -10% | -$49K | 0.08% | 218 |
|
2018
Q3 | $530K | Sell |
1,311
-113
| -8% | -$45.7K | 0.08% | 219 |
|
2018
Q2 | $491K | Sell |
1,424
-74
| -5% | -$25.5K | 0.08% | 220 |
|
2018
Q1 | $516K | Sell |
1,498
-38
| -2% | -$13.1K | 0.08% | 216 |
|
2017
Q4 | $577K | Buy |
1,536
+89
| +6% | +$33.4K | 0.09% | 201 |
|
2017
Q3 | $647K | Sell |
1,447
-14
| -1% | -$6.26K | 0.1% | 197 |
|
2017
Q2 | $717K | Sell |
1,461
-226
| -13% | -$111K | 0.11% | 187 |
|
2017
Q1 | $653K | Sell |
1,687
-287
| -15% | -$111K | 0.1% | 185 |
|
2016
Q4 | $725K | Buy |
1,974
+324
| +20% | +$119K | 0.11% | 185 |
|
2016
Q3 | $663K | Sell |
1,650
-2,479
| -60% | -$996K | 0.1% | 184 |
|
2016
Q2 | $1.44K | Sell |
4,129
-71
| -2% | -$25 | 0.11% | 188 |
|
2016
Q1 | $1.51M | Sell |
4,200
-382
| -8% | -$138K | 0.12% | 179 |
|
2015
Q4 | $2.49M | Sell |
4,582
-2,670
| -37% | -$1.45M | 0.21% | 114 |
|
2015
Q3 | $3.37M | Buy |
7,252
+5,685
| +363% | +$2.64M | 0.28% | 93 |
|
2015
Q2 | $799 | Sell |
1,567
-103
| -6% | -$53 | 0.12% | 209 |
|
2015
Q1 | $754 | Buy |
1,670
+137
| +9% | +$62 | 0.11% | 226 |
|
2014
Q4 | $629K | Sell |
1,533
-113
| -7% | -$46.4K | 0.09% | 204 |
|
2014
Q3 | $594K | Buy |
+1,646
| New | +$594K | 0.08% | 215 |
|